Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,278,088
-
Total 13F shares
-
1,286,937
-
Share change
-
+6,000
-
Total reported value
-
$25,805,000
-
Put/Call ratio
-
13%
-
Price per share
-
$20.08
-
Number of holders
-
28
-
Value change
-
+$120,000
-
Number of buys
-
1
Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) as of Q4 2013
As of 31 Dec 2013,
ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,286,937 shares.
The largest 10 holders included
Healthcare Value Capital, LLC, BlackRock Institutional Trust Company, N.A., KENNEDY CAPITAL MANAGEMENT, INC., VANGUARD GROUP INC, MUTUAL OF AMERICA CAPITAL MANAGEMENT CORP, ESSEX INVESTMENT MANAGEMENT CO LLC, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, BRIDGEWAY CAPITAL MANAGEMENT INC, and US BANCORP \DE\.
This page lists
28
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.